Xiaochen Zhao

4.6k total citations · 1 hit paper
85 papers, 2.3k citations indexed

About

Xiaochen Zhao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaochen Zhao has authored 85 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Xiaochen Zhao's work include Cancer Immunotherapy and Biomarkers (31 papers), Cancer Genomics and Diagnostics (15 papers) and Genetic factors in colorectal cancer (11 papers). Xiaochen Zhao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (31 papers), Cancer Genomics and Diagnostics (15 papers) and Genetic factors in colorectal cancer (11 papers). Xiaochen Zhao collaborates with scholars based in China, United States and Ethiopia. Xiaochen Zhao's co-authors include Lijun Liu, Yuezong Bai, Sandrine V. Pierre, Jianguo Sun, Guangji Wang, Amir Askari, Akintunde Bello, Sachin Agrawal, Guang Chen and Huizhong W. Tao and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Clinical Oncology.

In The Last Decade

Xiaochen Zhao

80 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer

2019 249 citations Xiaochen Zhao, Shangli Cai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaochen Zhao China	24	937	699	452	292	250	85	2.3k
Yaping Yang China	28	388 0.4×	876 1.3×	205 0.5×	238 0.8×	345 1.4×	107	2.8k
Lina Li China	26	309 0.3×	683 1.0×	306 0.7×	144 0.5×	260 1.0×	117	1.9k
Paola Nicoletti United States	25	287 0.3×	917 1.3×	374 0.8×	223 0.8×	209 0.8×	54	3.1k
Zhe Shen China	29	321 0.3×	1.2k 1.8×	569 1.3×	166 0.6×	420 1.7×	97	3.3k
Feng Gao China	32	956 1.0×	1.1k 1.6×	497 1.1×	225 0.8×	357 1.4×	138	3.7k
Liang Qiao China	27	610 0.7×	922 1.3×	104 0.2×	160 0.5×	170 0.7×	92	2.4k
Tao Jiang China	30	261 0.3×	1.1k 1.6×	380 0.8×	294 1.0×	641 2.6×	100	2.3k
Takashi Mori Japan	30	560 0.6×	632 0.9×	1.0k 2.3×	234 0.8×	105 0.4×	143	3.4k
Sandra J. Olson United States	33	414 0.4×	1.2k 1.8×	543 1.2×	234 0.8×	369 1.5×	49	3.1k

Countries citing papers authored by Xiaochen Zhao

Since Specialization

Citations

This map shows the geographic impact of Xiaochen Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Zhao more than expected).

Fields of papers citing papers by Xiaochen Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochen Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Zhao. The network helps show where Xiaochen Zhao may publish in the future.

Co-authorship network of co-authors of Xiaochen Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochen Zhao. A scholar is included among the top collaborators of Xiaochen Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochen Zhao. Xiaochen Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Wei, Jin Huang, Chunyi Peng, et al.. (2025). Cellular-skeleton-hosting polymer fluid gels with high damping and mechanical stability over an ultra-wide frequency breadth. Matter. 8(12). 102373–102373. 1 indexed citations

Wang, Xue, Feng Du, Jian Yue, et al.. (2023). Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer. Cancer Biology and Medicine. 20(2). 155–168. 7 indexed citations

Gong, Jun, Wei Xiong, Xu Wang, et al.. (2023). Gene variation profile and its potential correlation with clinical characteristics in HBV-associated HCC patients of Sichuan Han nationality in China. Asian Journal of Surgery. 46(10). 4371–4377. 2 indexed citations

Qi, Changsong, Yuezong Bai, Hui Chen, et al.. (2023). China special issue on gastrointestinal tumors—NTRK fusion in a large real‐world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment. International Journal of Cancer. 153(11). 1916–1927. 2 indexed citations

Zhao, Xiaochen, Wei Liu, Lulu Dong, et al.. (2023). The Extract of Pinellia Ternata-Induced Apoptosis of Leukemia Cells by Regulating the Expression of Bax, Bcl-2 and Caspase-3 Protein Expression in Mice. Transplantation Proceedings. 55(9). 2232–2240. 3 indexed citations

Chen, Tianxiang, Jia Huang, Shengping Shen, et al.. (2023). Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer. Annals of Surgical Oncology. 30(12). 7549–7560. 7 indexed citations

Li, Juan, et al.. (2023). Integrating machine learning algorithms to systematically assess reactive oxygen species levels to aid prognosis and novel treatments for triple -negative breast cancer patients. Frontiers in Immunology. 14. 1196054–1196054. 6 indexed citations

Liu, Jiayong, et al.. (2022). Case Report: A PD-L1-Positive Patient With Pleomorphic Rhabdomyosarcoma Achieving an Impressive Response to Immunotherapy. Frontiers in Immunology. 13. 815598–815598. 5 indexed citations

Xing, Yingying, et al.. (2021). Contributing Factors Affecting the Severity of Metro Escalator Injuries in the Guangzhou Metro, China. International Journal of Environmental Research and Public Health. 18(2). 651–651. 5 indexed citations

10.

Liang, Yan, Wěi Li, Zhengyi Zhao, et al.. (2021). The role of TGF-β pathway alterations in immune regulation as a potential pan-cancer biomarker in immunotherapy. Annals of Translational Medicine. 9(22). 1660–1660. 1 indexed citations

11.

Qu, Min, et al.. (2020). 1964P Genomic characteristics of homologous recombination in prostate cancer patients. Annals of Oncology. 31. S1105–S1105. 2 indexed citations

12.

Sun, Danyang, Junxun Ma, Jinliang Wang, et al.. (2019). Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer. Cancer Immunology Immunotherapy. 68(9). 1527–1535. 39 indexed citations

13.

Zhuang, Wu, Junxun Ma, Xudong Chen, et al.. (2018). The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel. Journal of Cancer. 9(13). 2302–2307. 20 indexed citations

14.

Long, Georgina V., Scott S. Tykodi, Jeffrey Schneider, et al.. (2018). Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer. Annals of Oncology. 29(11). 2208–2213. 122 indexed citations

15.

Wang, Guoqiang, Shangli Cai, Weiwei Liu, et al.. (2017). Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis. Schizophrenia Research. 185. 73–79. 25 indexed citations

16.

Zhao, Xiaochen, Satyendra Suryawanshi, Matthew Hruska, et al.. (2016). Assessment of nivolumab (Nivo) benefit-risk profile from a 240-mg flat dose versus a 3-mg/kg dosing regimen in patients (Pts) with solid tumors. Annals of Oncology. 27. vi376–vi376. 3 indexed citations

17.

Xu, Teng-Fei, Xiaochen Zhao, Yuntong Jiao, et al.. (2014). A Pathogenesis Related Protein, VpPR-10.1, from Vitis pseudoreticulata: An Insight of Its Mode of Antifungal Activity. PLoS ONE. 9(4). e95102–e95102. 33 indexed citations

18.

Liu, Qing, et al.. (2013). Impact of Microbubble-Enhanced Ultrasound on Liver Ethanol Ablation. Ultrasound in Medicine & Biology. 39(6). 1039–1046. 8 indexed citations

19.

Yang, Zhao, Lu Li, Qing Liu, et al.. (2011). Disruption of liver blood perfusion by microbubbles enhanced ultrasound. Zhonghua chaosheng yingxiangxue zazhi. 20(11). 988–991. 2 indexed citations

20.

Zhao, Xiaochen, et al.. (2011). Liver haemostasis using microbubble-enhanced ultrasound at a low acoustic intensity. European Radiology. 22(2). 379–386. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact